SCHEMBL2099456

SCHEMBL2099456

C1CCC2(C1)CNCN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5004160 0.97
SCHEMBL31659421 0.88
SCHEMBL8223868 0.81
SCHEMBL217626 0.80
SCHEMBL3463681 0.77
SCHEMBL734695 0.76
SCHEMBL700790 0.74 SOS1 (0.33)
SCHEMBL16877485 0.74
SCHEMBL17797606 0.74
SCHEMBL17797570 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250228865-A1 COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME SANOFI US SERVICES INC. (US) 2025-07-17 US disclosed
EP-4267539-A1 HISTONE DEACETYLASE INHIBITORS The University of Queensland (AU) 2023-11-01 EP disclosed
WO-2022133551-A1 HISTONE DEACETYLASE INHIBITORS THE UNIVERSITY OF QUEENSLAND (AU) 2022-06-30 WO disclosed
EP-2851120-A1 Polymeric salts and polymeric metal complexes Agency for Science, Technology and Research (SG) 2015-03-25 EP disclosed
EP-2530078-A1 THIAZOLE DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2012-12-05 EP disclosed
EP-2066601-B1 HYDROSILYLATION AGENCY SCIENCE TECH & RES (SG) 2012-10-24 EP disclosed
US-8163851-B2 Polymeric salts and poly-NHC-metal complexes INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY (SG) 2012-04-24 US disclosed
US-20100137608-A1 POLY-N-HETEROCYCLIC CARBENE TRANSITION METAL COMPLEXES AND N-HETEROCYCLIC CARBENE TRANSITION METAL COMPLEXES FOR CARBON-SULFUR AND CARBON-OXYGEN COUPLING REACTIONS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2010-06-03 US disclosed
US-20100016621-A1 Hydrosilylation AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2010-01-21 US disclosed
US-20090227740-A1 Polymeric Salts and Poly-NHC-Metal Complexes INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY (SG) 2009-09-10 US disclosed
EP-2066601-A1 HYDROSILYLATION Agency for Science, Technology And Research (SG) 2009-06-10 EP disclosed
EP-2001590-A1 POLYIMIDAZOLIUM SALTS AND POLY-NHC-METAL COMPLEXES Agency for Science, Technology and Research (SG) 2008-12-17 EP disclosed
WO-2008039154-A1 HYDROSILYLATION AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2008-04-03 WO disclosed
WO-2007114792-A1 POLYMERIC SALTS AND POLYMERIC METAL COMPLEXES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2007-10-11 WO disclosed
WO-2007114793-A1 POLYIMIDAZOLIUM SALTS AND POLY-NHC-METAL COMPLEXES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2007-10-11 WO disclosed
EP-1183241-B1 SPIROIMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM AVENTIS PHARMA GMBH (DE) 2003-09-17 EP disclosed
US-6399643-B1 ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-06-04 US disclosed
EP-1183241-A1 SPIROIMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
WO-2000069831-A1 SPIROIMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-23 WO disclosed
US-3979380-A INOTROPIC ACTIVITY, CARDIAC STIMULANTS AMERICAN HOME PRODUCTS CORPORATION (US) 1976-09-07 US disclosed